articleNatureJan 8, 2013Closed access

Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance

MDMeghna Das ThakurFSFernando SalangsangALAllison LandmanWRWilliam R. SellersNPNancy Pryer

Novartis (United States) · University of California, San Francisco · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

735
total citations
FWCI
45.02
Percentile
100%
References
22
Citations per year

Authors

9

Topics & keywords

Topics
Keywords
  • Vemurafenib
  • Melanoma
  • Medicine
  • Drug resistance
  • Drug
  • Cancer research
  • Dosing
  • Pharmacology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.